Back in 2007 the article
Tuberculosis screening on a health science campus: use of QuantiFERON-TB Gold Test for students and employees said
Tuberculin skin tests are still the preferred method for detecting present or past infection of TB.
Cellestis'
Chief Scientific Officer Dr Jim Rothel then
advised that the methodology used by the researchers was not that recommended by the CDC
the use of incorrect CDC guidelines in the Veeser et al1 manuscript... may raise some misconceptions for the reader about when and where QFT-G is recommended for use.
which was accepted by the authors
Dr Rothel is correct that the CDC guidelines quoted in the article were not the guidelines of December 2005.
I have spoken to Dr Rothel regarding these comments and stand corrected with his letter above. Please see the CDC Web site for the most current guidelines for IGRA assays for TB screening [October 2007]. These guidelines are changing as new screening tests emerge.
Kansas City has
taken note of guidelines
The plan is to be designed to reduce the risk of tuberculosis transmission and is to be based on the recommendations of the American Thoracic Society, the Centers for Disease Control and Prevention, and the Infectious Diseases Society of America
and passed a
bill for funds for a QuantiFERON Lab
AN ACT concerning the department of health and environment; creating the health information exchange — federal fund and the quanteFERON TB laboratory testing fund.
They
expressed concern over BCG and false positives
..many students have not had a tuberculosis screening which places all students, staff, and faculty at risk of contracting tuberculosis....Mr. Griffin discussed individuals vaccinated with BCG and false positives generated when the individual undergoes a tuberculosis skin test (TST).
which
led
to the
statement regarding
the requirement for all college students to have a TB test using Quantiferon, the universities want to contract with the KDHE Lab to do these tests and will need a fund to deposit these contractual service payments. The motion was seconded by Senator Kelly. Motion carried on a voice vote.
Thanks to 'doc-gt' and 'equusmedical'
